SLC25A22 DRIVES IMMUNE SUPPRESSION IN KRAS-MUTANT COLORECTAL CANCER VIA METABOLIC REGULATION OF CXCL1/CXCR2 AXIS

被引：0
|
作者：
Zhou, Qiming
Peng, Yao
Chan, Lam-Shing
Chen, Huarong
Kang, Wei
Nie, Yuqiang
Yu, Jun
Wong, Chi Chun
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su111
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 24 条
  • [1] SLC25A22 DRIVES IMMUNE SUPPRESSION IN KRAS-MUTANT COLORECTAL CANCER
    Zhou, Qiming
    Peng, Yao
    Chen, Lam-Shing
    Chen, Huarong
    Kang, Wei
    Nie, Yuqiang
    Yu, Jun
    Wong, Chi Chun
    GUT, 2021, 70 : A53 - A55
  • [2] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Zhou, Qiming
    Peng, Yao
    Ji, Fenfen
    Chen, Huarong
    Kang, Wei
    Chan, Lam-Shing
    Gou, Hongyan
    Lin, Yufeng
    Huang, Pingmei
    Chen, Danyu
    Wei, Qinyao
    Su, Hao
    Liang, Cong
    Zhang, Xiang
    Yu, Jun
    Wong, Chi Chun
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
    Qiming Zhou
    Yao Peng
    Fenfen Ji
    Huarong Chen
    Wei Kang
    Lam-Shing Chan
    Hongyan Gou
    Yufeng Lin
    Pingmei Huang
    Danyu Chen
    Qinyao Wei
    Hao Su
    Cong Liang
    Xiang Zhang
    Jun Yu
    Chi Chun Wong
    Nature Communications, 14
  • [4] SLC25A22 DRIVES ONCOMETABOLITE SUCCINATE TO PROMOTE WNT/ß-CATENIN SIGNALING AND CANCER STEMNESS IN KRAS-MUTANT COLORECTAL CANCER
    Wong, Chi Chun
    Xu, Jiaying
    Li, Weilin
    Qian, Yun
    Kang, Wei
    Wu, Jianlin
    Sung, Joseph J.
    Yu, Jun
    GASTROENTEROLOGY, 2019, 156 (06) : S188 - S188
  • [5] SLC25A22 Is Essential for Supporting Aspartate Biosynthesis and Is a Specific Vulnerability in KRAS-Mutant Colorectal Cancer
    Wong, Chi Chun
    Li, Xiaona
    Qian, Yun
    Xu, Jiaying
    Kang, Wei
    To, Ka Fai
    Sung, Joseph
    Cai, Zongwei
    Yu, Jun
    GASTROENTEROLOGY, 2016, 150 (04) : S139 - S139
  • [6] A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer
    Jin, Jiaying
    Li, Yijia
    Deng, Feiyang
    Yang, Long
    Lin, Yuxing
    Yang, Canyu
    Dai, Wenbing
    Zhang, Hua
    He, Bing
    Zhang, Qiang
    Wang, Xueqing
    NANO TODAY, 2024, 56
  • [7] LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer
    Li, Xiaona
    Chung, Arthur C. K.
    Li, Shangfu
    Wu, Lilan
    Xu, Jiaying
    Yu, Jun
    Wong, Chichun
    Cai, Zongwei
    ONCOTARGET, 2017, 8 (60) : 101333 - 101344
  • [8] Synthetic Lethal Interaction Between Oncogenic KRAS and Mitochondrial Glutamate Transporter SLC25A22 Unveils a Novel Therapeutic Target in KRAS-Mutant Colon Cancer
    Wong, Chi Chun
    Qian, Yun
    Zhao, Liuyang
    Kang, Wei
    To, Ka Fai
    Sung, Joseph J. Y.
    Yu, Jun
    GASTROENTEROLOGY, 2015, 148 (04) : S14 - S15
  • [9] CXCL1/CXCR2 is involved in white matter injury in neonatal rats via the gut–brain axis
    Can Yang
    Zhiyuan Feng
    Hong Deng
    Lu Dai
    Ling He
    Linlin Yin
    Jing Zhao
    BMC Neuroscience, 23
  • [10] KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
    Liao, Wenting
    Overman, Michael J.
    Boutin, Adam T.
    Shang, Xiaoying
    Zhao, Di
    Dey, Prasenjit
    Li, Jiexi
    Wang, Guocan
    Lan, Zhengdao
    Li, Jun
    Tang, Ming
    Jiang, Shan
    Ma, Xingdi
    Chen, Peiwen
    Katkhuda, Riham
    Korphaisarn, Krittiya
    Chakravarti, Deepavali
    Chang, Andrew
    Spring, Denise J.
    Chang, Qing
    Zhang, Jianhua
    Maru, Dipen M.
    Maeda, Dean Y.
    Zebala, John A.
    Kopetz, Scott
    Wang, Y. Alan
    DePinho, Ronald A.
    CANCER CELL, 2019, 35 (04) : 559 - +
123